Report Overview
Amlodipine is a calcium channel blocker widely used to manage high blood pressure (hypertension) and angina pectoris. It is available in various formulations, including amlodipine benzene sulfonate tablets, amlodipine mesylate tablets, and levoamlodipine maleic acid tablets. This medication is essential in cardiovascular therapy due to its effectiveness in lowering blood pressure and providing kidney protection.
Market Analysis
The global Amlodipine Market was valued at US$ 13.1 billion in 2024 and is projected to reach US$ 17.5 billion by 2032, exhibiting a CAGR of 3.8% during the forecast period (2024-2032).
Historical trends indicate steady growth in demand, driven by the rising prevalence of hypertension and heart diseases.
The increasing geriatric population and expanding healthcare access in emerging economies also contribute to market expansion.
Regional Analysis
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Competitor Analysis
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Amlodipine Benzene Sulfonate Tablet
Amlodipine Mesylate Tablet
Levoamlodipine Maleic Acid Tablet
